Current approaches to malaria vaccines

PE Duffy - Current opinion in microbiology, 2022 - Elsevier
Highlights•First malaria vaccine RTS, S induces anti-sporozoite antibodies to protect
children.•Whole-sporozoite vaccines induce T cells and antibodies and confer field …

Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein

TH Dickey, NH Tolia - Trends in parasitology, 2023 - cell.com
Malaria caused by the Plasmodium vivax parasite is a major global health burden. Immunity
against blood-stage infection reduces parasitemia and disease severity. Duffy-binding …

PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum

SW Scally, T Triglia, C Evelyn, BA Seager… - Nature …, 2022 - nature.com
The most severe form of malaria is caused by Plasmodium falciparum. These parasites
invade human erythrocytes, and an essential step in this process involves the ligand PfRh5 …

[HTML][HTML] The PfRCR complex bridges malaria parasite and erythrocyte during invasion

B Farrell, N Alam, MN Hart, A Jamwal, RJ Ragotte… - Nature, 2024 - nature.com
The symptoms of malaria occur during the blood stage of infection, when parasites invade
and replicate within human erythrocytes. The PfPCRCR complex, containing PfRH5 (refs.,) …

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

BG Williams, LDW King, D Pulido, D Quinkert… - Nature …, 2024 - nature.com
Reticulocyte-binding protein homologue 5 (RH5), a leading blood-stage Plasmodium
falciparum malaria vaccine target, interacts with cysteine-rich protective antigen (CyRPA) …

A critical review on human malaria and schistosomiasis vaccines: current state, recent advancements, and developments

AJ Siddiqui, J Bhardwaj, J Saxena, S Jahan, M Snoussi… - Vaccines, 2023 - mdpi.com
Malaria and schistosomiasis are two major parasitic diseases that remain leading causes of
morbidity and mortality worldwide. Co-infections of these two parasites are common in the …

Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes

A Jamwal, CF Constantin, S Hirschi, S Henrich, W Bildl… - Elife, 2023 - elifesciences.org
Basigin is an essential host receptor for invasion of Plasmodium falciparum into human
erythrocytes, interacting with parasite surface protein PfRH5. PfRH5 is a leading blood-stage …

[HTML][HTML] The essential malaria protein PfCyRPA targets glycans to invade erythrocytes

CJ Day, P Favuzza, S Bielfeld, T Haselhorst, L Seefeldt… - Cell Reports, 2024 - cell.com
Plasmodium falciparum is a human-adapted apicomplexan parasite that causes the most
dangerous form of malaria. P. falciparum cysteine-rich protective antigen (PfCyRPA) is an …

RH5. 1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5. 1 in a preclinical setting

J Healer, JK Thompson, KL Mackwell… - Frontiers in Cellular …, 2022 - frontiersin.org
Background RH5 is the leading vaccine candidate for the Plasmodium falciparum blood
stage and has shown impact on parasite growth in the blood in a human clinical trial. RH5 …

The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals

M Tamborrini, A Schäfer, J Hauser, L Zou, DH Paris… - Malaria Journal, 2023 - Springer
Background Plasmodium falciparum cysteine-rich protective antigen (Pf CyRPA) is an
invasion complex protein essential for erythrocyte invasion. In contrast to several previously …